Showing results (71-80 of 183) with videos related to

Sort By:
Pageof 19
Journal of Cellular Physiology|November 18, 2006
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomasArianna Bottoni, Maria Chiara Zatelli, Manuela Ferracin, et al.
Molecular Cancer Research : MCR|December 11, 2013
p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinomaFrancesca Fornari, Maddalena Milazzo, Marzia Galassi, et al.
European Journal of Immunology|November 22, 2023
Circulating CD8 lymphocytes predict response to atezolizumab-bevacizumab in hepatocellular carcinomaLaura Gramantieri, Fabrizia Suzzi, Cristian Bassi, et al.
Cell Death & Disease|November 18, 2021
P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cellsAnna Pegoraro, Elena De Marchi, Manuela Ferracin, et al.
Molecular Cancer|October 30, 2013
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expressionManuela Ferracin, Cristian Bassi, Massimo Pedriali, et al.
European Journal of Cancer Care|August 15, 2019
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot studyLaura Lupini, Gennaro Scutiero, Piergiorgio Iannone, et al.
Oncogene|April 24, 2002
Loss of methylation at chromosome 11p15.5 is common in human adult tumorsRosaria A M Scelfo, Christine Schwienbacher, Angelo Veronese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivoManuela Sarti, Cinzia Sevignani, George A Calin, et al.
Scientific Reports|August 9, 2024
Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapyLucilla D'Abundo, Cristian Bassi, Elisa Callegari, et al.
Oncotarget|June 20, 2015
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse modelAntonella Bresin, Elisa Callegari, Lucilla D'Abundo, et al.
Pageof 19